# Isomorphic Labs — Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations

- Company: Isomorphic Labs (isomorphiclabs.com)
- Announced: 2024-01-07
- Category: partnership-acquisition
- Coverage: not counted
- Announcement: yes
- Group: announcements
- Source: https://www.isomorphiclabs.com/articles/isomorphic-labs-kicks-off-2024-with-two-pharmaceutical-collaborations
- Record: https://forck.live/items/19139-isomorphic-labs-kicks-off-2024-with-two-pharmaceutical-collaborations
- Subject: Drug Design Engine / AlphaFold

Isomorphic Labs announced strategic collaborations with Eli Lilly and Company and Novartis. The partnerships are multi-target, focused on small molecules, and have a potential combined value of nearly $3 billion, excluding future royalties. Isomorphic Labs will receive $45 million upfront from Eli Lilly and $37.5 million upfront from Novartis.

## Evidence

Verbatim from https://www.isomorphiclabs.com/articles/isomorphic-labs-kicks-off-2024-with-two-pharmaceutical-collaborations:

> Isomorphic Labs announces strategic collaborations with two of the world’s leading pharmaceutical companies, Eli Lilly and Company and Novartis. These partnerships have the potential to be worth nearly $3 billion to Isomorphic Labs, excluding any royalties that may result from future drug sales, and are testament to Isomorphic’s approach to drug design and the progress we are making.

---

Record: https://forck.live/items/19139-isomorphic-labs-kicks-off-2024-with-two-pharmaceutical-collaborations
Catalogue: https://forck.live/llms.txt
Current issue: https://forck.live/feed.md